Abstract View

Author(s): Dr. Sundhararajan R1, L K. Dhivya*2, Mohan. N3, Paul Christober. M4, Surya Prakash. S5, Tamil selvan. P6

Email(s): 1lkdhivya97@gmail.com

Address:

    Mohammed Sathak College of Pharmacy, Chennai, Tamilnadu

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5207  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Ethanolic extract of Euphorbia hirta where evaluated for their carbohydrate enzyme inhibition, it is the key indicator for anti-diabetic potential. The inhibitory activity of EEEH against carbohydrate-digesting enzymes was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-amylase inhibitory activity, with an IC₅₀ value of 1.16 mg/mL, indicating measurable enzyme suppression. In comparison, acarbose demonstrated significantly stronger inhibition, as reflected by a lower IC₅₀ value of 0.42 mg/mL. The inhibitory activity of EEEH against α-glucosidase was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-glucosidase inhibitory activity, with an IC₅₀ value of 1.21 mg/mL, indicating appreciable enzyme suppression. In contrast, acarbose showed stronger inhibitory potential, as evidenced by a lower IC₅₀ value of 0.44 mg/mL.

Cite this article:
Dr. Sundhararajan R, L K. Dhivya*, Mohan. N, Paul Christober. M, Surya Prakash. S, Tamil selvan. Evaluation of In-vitro Anti-diabetic activity in Ethanolic Stem Extract of Euphobia hirta. IJRPAS, February 2026; 5(2): 88-92.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5207


1.Kausar, J.; Muthumani, D.; Hedina, A.; Ramasamy, S.; Anand, V. Review of the phytochemical and

   pharmacological activities of Euphorbia hirta Linn. Pharmacogn. J. 2016, 8, 310–313. [CrossRef]

2. Sharma, M.; Sheliya, M.A.; Begum, R.; Pillai, K.K.; Aeri, V.; Mir, S.R.; Ali, A.; Sharma, M. In vitro

    α-glucosidase and α-amylase inhibition by aqueous, hydroalcoholic, and alcoholic extract of Euphorbia hirta L. Drug Dev. Ther. 2016, 7, 26. [CrossRef]

3.Sharma, N.K.; Dey, S.; Prasad, R. In vitro antioxidant potential evaluation of Euphorbia hirta L.

    Pharmacologyonline 2007, 1, 91–98.

4. Kumar, S.; Malhotra, R.; Kumar, D. Euphorbia hirta: Its chemistry, traditional and medicinal uses,

    and pharmacological activities. Pharmacogn. Rev. 2010, 4, 58–61. [CrossRef]

5. Tran, N.; Tran, M.; Truong, H.; Le, L. Spray-Drying Microencapsulation of High Concentration of Bioactive Compounds Fragments from Euphorbia hirta L. Extract and Their Effect on Diabetes Mellitus. Foods 2020, 9, 881. [CrossRef]

6. McCue P.P and Shetty, K. “Inhibitory effects of rosmarinic acid extracts on porcine pancreatic

    amylase in vitro,” Asia Pacific Journal of Clinical Nutrition, vol. 13, no. 1, pp. 101–106, 2004.

Related Images:



Recent Images



Phytosomes: Lipid-Based Nanocarriers for Enhanced Herbal Bioavailability
A Review on Nanosponges: Versatile Carriers for Enhanced Drug Delivery
Risk-Based Matrix Approach for Determining Effort, Formality, and Documentation in Cleaning Validation
Transformation of Traditional Bajrang Lep into a Modern Polyherbal Hydrogel: Formulation and Evaluation of a Topical Anti-inflammatory Preparation
Clinical and Observational Study on Sickle Cell Disease in Akkalkuwa Region, Maharashtra
Understanding Drug Development Failures: Scientific, Financial, and Regulatory Drivers
Pluronic-Lecithin Organogels as A Novel Carrier for Dermal Delivery: A Review
Synergistic Therapeutic Potential of Elaeocarpus ganitrus and Withania somnifera in Epilepsy Management: A Comprehensive Review
Comprehensive Review of Co-Processing Technology in Pharmaceuticals
Investigation and Effective CAPA System:  The Biggest Opportunities of the Investigation CAPA System & How to Fix Them

Tags